Skip to content

Data Therapy Collection to Evaluate Performances of an Automated Insulin Titration Algorithm Compared to Standard Method of Titration

Data Therapy Collection to Evaluate Performances of an Automated Insulin Titration Algorithm Compared to Standard Method of Titration

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05098301
Acronym
GLUCAL3
Enrollment
30
Registered
2021-10-28
Start date
2021-11-30
Completion date
2022-07-01
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Diabetes, Functional insulin therapy

Brief summary

A data collection of blood glucose values, insulin, meal composition will be performed for a period of two months, to evaluate the performances of an automated insulin titration algorithm

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Person with Type 1 diabetes * Treated by basal-bolus therapy with MDI or pump * Patient with social security or beneficiary of medical coverage * Patient using functional insulin therapy or starting and education course * Patient able to read and understand the procedure, and able to express consent for study protocol

Exclusion criteria

* Patient abusing substances * Patient deprived of liberty by judicial or administrative decision, person subject to a legal protection measure, patient having a psychological condition making him unable to follow and understand study protocol

Design outcomes

Primary

MeasureTime frameDescription
evaluate the performances of an insulin titration algorithmday 1to evaluate the performances of an insulin titration algorithm to calculate insulin therapy parameters at the same precision of an expert practitioner

Secondary

MeasureTime frameDescription
measure time-in-range evolution adjustment of insulin therapy parametersday 1to measure time-in-range evolution before and after adjustment of insulin therapy parameters by practitioner

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026